However, since the 1990s, boronophenylalanine (BPA) [4] has increasingly replaced BSH [5,6] because of its higher tumor selectivity, exploiting the overexpression of amino acid transporters (mainly LAT-1) in tumor cells [7,8,9]. Here, SLC38A7 is linked to neoplasm.